Skip to main content
NIH funding notice PA-16-312

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21)

Closed on January 24, 2018.

Posted
June 7, 2016
Close date
January 24, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $435,375 in first-year total cost, median $217,688.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 SBIB-H (82)]1
  2. Xenobiotic and Nutrient Disposition and Action Study Section[XNDA]1

Most frequent institutions

  1. CINCINNATI CHILDRENS HOSP MED CTR1
  2. INDIANA UNIVERSITY INDIANAPOLIS1
Competing awards under PA-16-312 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Neonatal PBPK-PD Modeling of Morphine Incorporated with OCT1 Genotype-dependent Developmental Expression1R21HD095418-01EMOTO, CHIECINCINNATI CHILDRENS HOSP MED CTR, OH$238,500XNDA
2018Bedside prediction of opioid-induced respiratory depression in children with pupillometry1R21HD094311-01SADHASIVAM, SENTHILKUMARINDIANA UNIVERSITY INDIANAPOLIS, IN$196,875ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-16-312: Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21) | ScienceDex | ConductScience